jueves, 18 de abril de 2019

ALCON hasta la vista .../ Crónica de una despedida anunciada, Vas Narasimhan (Ceo Novartis)

"This is an incredibly exciting day for both Novartis and Alcon.  
Alcon has demonstrated consistent growth, and is coming to market from a position of strength. We wish them the very best for the future. At Novartis, we continue to reimagine ourselves as a leading medicines company powered by breakthrough medicines, data science and advanced therapy platforms. We are well positioned for the future and I am excited for our associates, our investors, and most importantly for patients." (Más)

Ver también:

No hay comentarios: